ReviewAbdominal radiology (New York)2026
Debunking Common Misconceptions About Percutaneous Abdominal Interventions.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary splenic diffuse large B-cell lymphoma masquerading as systemic lupus erythematosus: a case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Percutaneous image-guided interventions are minimally invasive alternatives to surgery for diagnosis and management of various abdominal disease processes. However, persistent misconceptions about these procedures continue to hinder their appropriate use. This review addresses common myths that can lead to unnecessary treatment delays or use of more invasive interventions, including concerns about the safety of splenic biopsy, rigid contraindications for antiplatelet medication use, bleeding risks with direct liver mass puncture, tumor seeding from renal biopsies, complications from multiple liver biopsy passes, and increased risk of liver biopsy in the setting of ascites. By clarifying these issues, this article aims to promote evidence-based use of percutaneous procedures.
Indexed as
Identifiers
40844595What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.